American Century Companies’s Kyverna Therapeutics KYTX Stock Holding History

American Century Companies's KYTX Position: Q2 2026 in Review

American Century Companies increased its Kyverna Therapeutics (KYTX) stake by 30% in Q2 2026, buying an estimated $143K and bringing the position to 69,351 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

American Century Companies first reported a position in KYTX in Q3 2025 and has held it in 4 quarters since. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

• American Century Companies held 69,351 shares of Kyverna Therapeutics worth $618K as of Q2 2026.
• American Century Companies bought 16,116 Kyverna Therapeutics shares in Q2 2026, an estimated $143K.
• Kyverna Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2537 holding.
• American Century Companies first reported a position in Kyverna Therapeutics in Q3 2025 and has held it in 4 quarters since.
• 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.